Contact Us directly

Britex Place, Mirra Crt Bundoora VIC 3083
t (03) 9466 9000 f (03) 9466 9044


Unit 1/8 Principal Link Malaga WA 6090
t (08) 9249 5464 f (08) 9248 6893


U 11/16 Northumberland Drv Taren Point NSW 2229
t (02) 9531 2100 f (02) 9531 2800


The Britex Group SA State Office
t 1300 764 744 f 1300 784 306


19 Manilla St East Brisbane QLD 4169
t (07) 3363 2400 f (07) 3363 2444

or send us an email

CSL Behring, Australia, Case Studies - Britex Metal Products

You are here : » » CSL Behring, Australia

CSL Behring, Australia

CSL Behring, Australia

Builder: Monaco Hickey

Architect: A5 Architects

Est. Project Value: $40 million

Britex Project Manager: Mr. Scott Fowler

Britex Project Role

Britex was engaged by the building contractor to manufacture and install specially fabricated stainless steel fixture for the project. Given the nature of the site we worked closely with the architect and provided consultation on fabrication design methods that met the strict guidelines required for this highly controlled sterile environment. Further to this close collaboration, the process included generating shop drawings, consultation in fixture design, manufacturing each fixture, project managing and coordinating the production of fixtures and installing the fixtures on site in conjunction with the primary contractor.

Stainless steel works and fixtures for the project included:

  • Stainless Steel Joinery
  • Garment cabinets
  • Process sinks (grates)
  • Protective clothing dispenser
  • Wash Basins
  • Coat Hooks/ Shoe Racks
  • Shelving and Benching
  • Work Station & PC cupboards

About the Development

CSL Behring is one of the world’s leading plasma protein biotherapeutic companies specialising in the manufacture of therapies for the treatment of rare and serious diseases. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent haemolytic diseases in newborns.

CSL Behring Australia supports all aspects of the process from the collection and testing of donated plasma through to the production of a range of plasma-derived products. CSL Behring is the chosen national fractionator of Australia, New Zealand, Hong Kong, Malaysia, Singapore and Taiwan.

Source: CSL Website 04/14